COVID-19 and nutra research: Where does the industry need to focus its scientific endeavours?
The COVID-19 pandemic had seen a spike in demand for immunity-boosting products, but what scope was there for new and credible research to examine if nutra products have a role to play in helping tackle the crisis?
We spoke to three respected industry professionals, Dilip Ghosh, the director of Nutriconnect in Australia; Sandeep Gupta, chief founder and director of India’s Expert Nutraceutical Advisory Council (ENAC) and Nutraworks; and Dr Anish Desai, director at Intellimed Healthcare Solutions.
CEO of Gencor Pacific, R. V Venkatesh, also gave insights on plans to conduct a human clinical trial to validate the effectiveness of palmitoylethanolamide (PEA) in symptomatic relief of the flu symptoms.
A common point brought up by the experts was the need for the government and industry to work together in the areas of new research and regulatory adjustment.